Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Drug Resistance

  Free Subscription


21.01.2019

2 Antimicrob Agents Chemother
1 Clin Infect Dis
4 Emerg Infect Dis
14 Int J Antimicrob Agents
1 J Antimicrob Chemother
3 J Infect Chemother
1 J Med Microbiol
1 Nature
1 PLoS Comput Biol
3 PLoS Genet
2 PLoS Med
5 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. GELADARI A, Simitsopoulou M, Antachopoulos C, Roilides E, et al
    Dose-dependent Synergistic Interactions of Colistin with Rifampicin, Meropenem and Tigecycline against Carbapenem-resistant Klebsiella pneumoniae Biofilms.
    Antimicrob Agents Chemother. 2019 Jan 14. pii: AAC.02357.
    PubMed     Text format     Abstract available

  2. VALENTINE-KING MA, Cisneros K, James MO, Huigens RW 3rd, et al
    Turning the Tide against Antibiotic Resistance by Evaluating Novel, Halogenated Phenazine, Quinoline, and NH125 Compounds against Ureaplasma spp. Clinical Isolates and Mycoplasma Type Strains.
    Antimicrob Agents Chemother. 2019 Jan 14. pii: AAC.02265.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  3. PAPANICOLAOU GA, Ustun C, Young JH, Chen M, et al
    Bloodstream infection (BSI) due to Vancomycin-Resistant Enterococcus (VRE) is associated with increased mortality after hematopoietic cell transplantation for acute leukemia and myelodysplastic syndrome: A multicenter, retrospective cohort study.
    Clin Infect Dis. 2019 Jan 14. pii: 5289185. doi: 10.1093.
    PubMed     Text format     Abstract available


    Emerg Infect Dis

  4. LOUTET MG, Davidson JA, Brown T, Dedicoat M, et al
    Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000-2015.
    Emerg Infect Dis. 2018;24:524-533.
    PubMed     Text format     Abstract available

  5. NAIK PR, Moonan PK, Nirgude AS, Shewade HD, et al
    Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India.
    Emerg Infect Dis. 2018;24:478-484.
    PubMed     Text format     Abstract available

  6. RANDO-SEGURA A, Aznar ML, Moreno MM, Espasa M, et al
    Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.
    Emerg Infect Dis. 2018;24:569-572.
    PubMed     Text format     Abstract available

  7. CHERNYAEVA E, Rotkevich M, Krasheninnikova K, Yurchenko A, et al
    Whole-Genome Analysis of Mycobacterium tuberculosis from Patients with Tuberculous Spondylitis, Russia.
    Emerg Infect Dis. 2018;24:579-583.
    PubMed     Text format     Abstract available


    Int J Antimicrob Agents

  8. CROUGHS PD, Klaassen CHW, van Rosmalen J, Maghdid DM, et al
    Unexpected mechanisms of resistance in Dutch Pseudomonas aeruginosa isolates collected during 14 years of surveillance.
    Int J Antimicrob Agents. 2018;52:407-410.
    PubMed     Text format     Abstract available

  9. KHOO AL, Zhao YJ, Teng M, Ying D, et al
    Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia.
    Int J Antimicrob Agents. 2018;52:350-357.
    PubMed     Text format     Abstract available

  10. LOMOVSKAYA O, Sun D, Rubio-Aparicio D, Nelson KJ, et al
    Absence of TetB identifies minocycline-susceptible isolates of Acinetobacter baumannii.
    Int J Antimicrob Agents. 2018;52:404-406.
    PubMed     Text format     Abstract available

  11. SCOTT AM, Beller E, Glasziou P, Clark J, et al
    Is antimicrobial administration to food animals a direct threat to human health? A rapid systematic review.
    Int J Antimicrob Agents. 2018;52:316-323.
    PubMed     Text format     Abstract available

  12. PROTONOTARIOU E, Poulou A, Politi L, Sgouropoulos I, et al
    Hospital outbreak due to a Klebsiella pneumoniae ST147 clonal strain co-producing KPC-2 and VIM-1 carbapenemases in a tertiary teaching hospital in Northern Greece.
    Int J Antimicrob Agents. 2018;52:331-337.
    PubMed     Text format     Abstract available

  13. CHIRAKUL S, Somprasong N, Norris MH, Wuthiekanun V, et al
    Burkholderia pseudomallei acquired ceftazidime resistance due to gene duplication and amplification.
    Int J Antimicrob Agents. 2019 Jan 9. pii: S0924-8579(19)30003.
    PubMed     Text format     Abstract available

  14. COURTOIS N, Caspar Y, Maurin M
    Phenotypic and genetic resistance traits of Pseudomonas aeruginosa strains infecting cystic fibrosis patients: A French cohort study.
    Int J Antimicrob Agents. 2018;52:358-364.
    PubMed     Text format     Abstract available

  15. LIM SC, Androga GO, Knight DR, Moono P, et al
    Antimicrobial susceptibility of Clostridium difficile isolated from food and environmental sources in Western Australia.
    Int J Antimicrob Agents. 2018;52:411-415.
    PubMed     Text format     Abstract available

  16. MCKINNON J, Roy Chowdhury P, Djordjevic SP
    Genomic analysis of multidrug-resistant Escherichia coli ST58 causing urosepsis.
    Int J Antimicrob Agents. 2018;52:430-435.
    PubMed     Text format     Abstract available

  17. TANSARLI GS, Papaparaskevas J, Balaska M, Samarkos M, et al
    Colistin resistance in carbapenemase-producing Klebsiella pneumoniae bloodstream isolates: Evolution over 15 years and temporal association with colistin use by time series analysis.
    Int J Antimicrob Agents. 2018;52:397-403.
    PubMed     Text format     Abstract available

  18. CHEN CM, Huang M, Wu HJ, Guo MK, et al
    Identification of CFE-2, a new plasmid-encoded AmpC beta-lactamase from a clinical isolate of Citrobacter freundii.
    Int J Antimicrob Agents. 2018;52:421-424.
    PubMed     Text format     Abstract available

  19. KIM SJ, Ko KS
    Diverse genetic alterations responsible for post-exposure colistin resistance in populations of the same strain of Klebsiella pneumoniae.
    Int J Antimicrob Agents. 2018;52:425-429.
    PubMed     Text format     Abstract available

  20. MACAUX L, Ndoye O, Cordel H, Pomares TB, et al
    Extensively-drug-resistant bacteria carriers among overseas travellers: one-third had not been hospitalized previously.
    Int J Antimicrob Agents. 2018;52:385-389.
    PubMed     Text format     Abstract available

  21. DIEP JK, Covelli J, Sharma R, Ruszaj DM, et al
    Comparison of the composition and in vitro activity of polymyxin B products.
    Int J Antimicrob Agents. 2018;52:365-371.
    PubMed     Text format     Abstract available


    J Antimicrob Chemother

  22. FERNANDEZ-ORTH D, Miro E, Brown-Jaque M, Rodriguez-Rubio L, et al
    Faecal phageome of healthy individuals: presence of antibiotic resistance genes and variations caused by ciprofloxacin treatment.
    J Antimicrob Chemother. 2019 Jan 10. pii: 5288153. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Infect Chemother

  23. ELJAALY K, Enani MA, Al-Tawfiq JA
    Impact of carbapenem versus non-carbapenem treatment on the rates of superinfection: A meta-analysis of randomized controlled trials.
    J Infect Chemother. 2018;24:915-920.
    PubMed     Text format     Abstract available

  24. HARUKI Y, Hagiya H, Haruki M, Sugiyama T, et al
    Clinical characteristics and outcome of critically ill patients with bacteremia caused by extended-spectrum beta-lactamase-producing and non-producing Escherichia coli.
    J Infect Chemother. 2018;24:944-947.
    PubMed     Text format     Abstract available

  25. TARUMOTO N, Kodana M, Watanabe N, Sakai J, et al
    First report of the isolation of blaIMI-1-producing colistin-heteroresistant Enterobacter cloacae in Japan, September 2016.
    J Infect Chemother. 2018;24:941-943.
    PubMed     Text format     Abstract available


    J Med Microbiol

  26. ZHANG H, Zheng L, Zhao J, Ding S, et al
    Investigation of fluoroquinolone resistance mechanism in Mycoplasma hominis isolated from urogenital samples in a Chinese hospital.
    J Med Microbiol. 2019 Jan 11. doi: 10.1099/jmm.0.000913.
    PubMed     Text format     Abstract available


    Nature

  27. BROCHADO AR, Telzerow A, Bobonis J, Banzhaf M, et al
    Species-specific activity of antibacterial drug combinations.
    Nature. 2018;559:259-263.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  28. VENUGOPAL V, Padmanabhan P, Raja R, Dixit NM, et al
    Modelling how responsiveness to interferon improves interferon-free treatment of hepatitis C virus infection.
    PLoS Comput Biol. 2018;14:e1006335.
    PubMed     Text format     Abstract available


    PLoS Genet

  29. PATEL V, Wu Q, Chandrangsu P, Helmann JD, et al
    A metabolic checkpoint protein GlmR is important for diverting carbon into peptidoglycan biosynthesis in Bacillus subtilis.
    PLoS Genet. 2018;14:e1007689.
    PubMed     Text format     Abstract available

  30. SCORTTI M, Han L, Alvarez S, Leclercq A, et al
    Epistatic control of intrinsic resistance by virulence genes in Listeria.
    PLoS Genet. 2018;14:e1007525.
    PubMed     Text format     Abstract available

  31. GANGULY A, Guo L, Sun L, Suo F, et al
    Tdp1 processes chromate-induced single-strand DNA breaks that collapse replication forks.
    PLoS Genet. 2018;14:e1007595.
    PubMed     Text format     Abstract available


    PLoS Med

  32. SCHAR D, Sommanustweechai A, Laxminarayan R, Tangcharoensathien V, et al
    Surveillance of antimicrobial consumption in animal production sectors of low- and middle-income countries: Optimizing use and addressing antimicrobial resistance.
    PLoS Med. 2018;15:e1002521.
    PubMed     Text format     Abstract available

  33. YIN YP, Han Y, Dai XQ, Zheng HP, et al
    Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: A retrospective study of national surveillance data from 2013 to 2016.
    PLoS Med. 2018;15:e1002499.
    PubMed     Text format     Abstract available


    PLoS One

  34. LI Y, Jia W, Lei G, Zhao D, et al
    Diagnostic efficiency of Xpert MTB/RIF assay for osteoarticular tuberculosis in patients with inflammatory arthritis in China.
    PLoS One. 2018;13:e0198600.
    PubMed     Text format     Abstract available

  35. PERRIER M, Desire N, Storto A, Todesco E, et al
    Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants.
    PLoS One. 2018;13:e0198334.
    PubMed     Text format     Abstract available

  36. MAWATARI S, Oda K, Tabu K, Ijuin S, et al
    The co-existence of NS5A and NS5B resistance-associated substitutions is associated with virologic failure in Hepatitis C Virus genotype 1 patients treated with sofosbuvir and ledipasvir.
    PLoS One. 2018;13:e0198642.
    PubMed     Text format     Abstract available

  37. NONAKA L, Yamamoto T, Maruyama F, Hirose Y, et al
    Interplay of a non-conjugative integrative element and a conjugative plasmid in the spread of antibiotic resistance via suicidal plasmid transfer from an aquaculture Vibrio isolate.
    PLoS One. 2018;13:e0198613.
    PubMed     Text format     Abstract available

  38. SHIBABAW A, Gelaw B, Wang SH, Tessema B, et al
    Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    PLoS One. 2018;13:e0198080.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  39. COPIN R, Sause WE, Fulmer Y, Balasubramanian D, et al
    Sequential evolution of virulence and resistance during clonal spread of community-acquired methicillin-resistant Staphylococcus aureus.
    Proc Natl Acad Sci U S A. 2019 Jan 11. pii: 1814265116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: